The previous page is sending you to https://www.prnewswire.com/news-releases/actinium-announces-clinical-trial-to-study-iomab-act-targeted-radiotherapy-conditioning-with-leading-fda-approved-commercial-car-t-cell-therapy-302098890.html.

 If you do not want to visit that page, you can return to the previous page.